Skip Navigation



Carcinogenesis Advance Access published online on January 18, 2007
Carcinogenesis, doi:10.1093/carcin/bgm006
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/3/519    most recent
bgm006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Besaratinia, A.
Right arrow Articles by Pfeifer, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Besaratinia, A.
Right arrow Articles by Pfeifer, G. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A review of mechanisms of acrylamide carcinogenicity

Ahmad Besaratinia* and Gerd P. Pfeifer

Division of Biology, Beckman Research Institute of the City of Hope National Medical Center, 1450 East Duarte Road, Duarte, CA 91010, USA

* Correspondence to: ania{at}coh.org, Tel: (626) 256 4673 ext: 65918, Fax: (626) 358 7703

The fact that acrylamide, a proven rodent carcinogen, is present in significant quantities (up to several mg/kg of foodstuff) in a wide range of commonly consumed human foods is alarming. Attempts to determine a possible involvement of dietary acrylamide in human cancers have not been conclusive, however. To resolve the carcinogenicity of acrylamide to humans, the as yet unknown mechanism of action of acrylamide needs to be unraveled. The present review is a synopsis of research on the known and hypothetical modes of action of acrylamide of relevance for carcinogenesis. Both genotoxic and non-genotoxic modes of action of acrylamide are discussed with special emphasis on DNA-adduct targeted mutagenesis. Mechanistic data are presented from various experimental systems including in vitro experiments and in vivo rodent and human studies with special focus on mouse models. Updated human exposure data, estimates of daily intake of dietary acrylamide in different populations, and the corresponding cancer risk assessments are provided. The significant gaps in knowledge, which currently preclude a more definitive evaluation of human cancer risk due to exposure to dietary acrylamide are highlighted. Future directions for research on acrylamide and cancer are outlined, and potential challenges are underscored.

Key Words: Acrylamide • cancer • diet • DNA adducts • glycidamide • hemoglobin • mutations


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
B. I. Ghanayem, R. Bai, and L. T. Burka
Effect of Dose Volume on the Toxicokinetics of Acrylamide and Its Metabolites and 2-Deoxy-D-glucose
Drug Metab. Dispos., February 1, 2009; 37(2): 259 - 263.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, G. Landberg, H. Olsson, and E. Wirfalt
Plant foods and oestrogen receptor {alpha}- and {beta}-defined breast cancer: observations from the Malmo Diet and Cancer cohort
Carcinogenesis, November 1, 2008; 29(11): 2203 - 2209.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. G. F. Hogervorst, L. J. Schouten, E. J. M. Konings, R. A. Goldbohm, and P. A. van den Brandt
Dietary Acrylamide Intake Is Not Associated with Gastrointestinal Cancer Risk
J. Nutr., November 1, 2008; 138(11): 2229 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
L. Ao, S.-X. Liu, M.-S. Yang, C.-C. Fong, H. An, and J. Cao
Acrylamide-induced molecular mutation spectra at HPRT locus in human promyelocytic leukaemia HL-60 and NB4 cell lines
Mutagenesis, July 1, 2008; 23(4): 309 - 315.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. G Hogervorst, L. J Schouten, E. J Konings, R A. Goldbohm, and P. A van den Brandt
Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1428 - 1438.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.